"Journal Data Filtered By:  Selected Categories: ONCOLOGY;OPERATIONS RESEARCH & MANAGEMENT SCIENCE;OPHTHALMOLOGY Selected Editions: SCIE;SSCI;AHCI;ESCI Selected JCR Year: 2022 Selected Category Schema: WOS Selected Open Access: N Indicator: Default"

Journal name,JCR Abbreviation,ISSN,eISSN,Category,Total Citations,2022 JIF,JIF Quartile,2022 JCI,% of OA Gold
"CA-A CANCER JOURNAL FOR CLINICIANS","CA-CANCER J CLIN","0007-9235","1542-4863","ONCOLOGY - SCIE","66,163","254.7","Q1","130.54","92.31"%,
"Nature Reviews Clinical Oncology","NAT REV CLIN ONCOL","1759-4774","1759-4782","ONCOLOGY - SCIE","26,127","78.8","Q1","9.09","2.13"%,
"NATURE REVIEWS CANCER","NAT REV CANCER","1474-175X","1474-1768","ONCOLOGY - SCIE","63,667","78.5","Q1","8.86","0.72"%,
"LANCET ONCOLOGY","LANCET ONCOL","1470-2045","1474-5488","ONCOLOGY - SCIE","77,245","51.1","Q1","9.03","14.6"%,
"ANNALS OF ONCOLOGY","ANN ONCOL","0923-7534","1569-8041","ONCOLOGY - SCIE","67,195","50.5","Q1","6.41","75.48"%,
"CANCER CELL","CANCER CELL","1535-6108","1878-3686","ONCOLOGY - SCIE","55,579","50.3","Q1","6.44","71.6"%,
"JOURNAL OF CLINICAL ONCOLOGY","J CLIN ONCOL","0732-183X","1527-7755","ONCOLOGY - SCIE","180,328","45.4","Q1","5.58","26.55"%,
"Molecular Cancer","MOL CANCER","N/A","1476-4598","ONCOLOGY - SCIE","36,241","37.3","Q1","5.43","100"%,
"Cancer Discovery","CANCER DISCOV","2159-8274","2159-8290","ONCOLOGY - SCIE","33,141","29.1","Q1","5.89","25.18"%,
"Journal of Hematology & Oncology","J HEMATOL ONCOL","N/A","1756-8722","ONCOLOGY - SCIE","20,030","28.5","Q1","3.57","99.75"%,
"JAMA Oncology","JAMA ONCOL","2374-2437","2374-2445","ONCOLOGY - SCIE","28,702","28.4","Q1","5.09","19.7"%,
"Nature Cancer","NAT CANCER","N/A","2662-1347","ONCOLOGY - SCIE","4,262","22.7","Q1","4.38","14.5"%,
"Journal of Thoracic Oncology","J THORAC ONCOL","1556-0864","1556-1380","ONCOLOGY - SCIE","27,703","20.4","Q1","3.52","81.59"%,
"Trends in Cancer","TRENDS CANCER","2405-8025","2405-8033","ONCOLOGY - SCIE","7,424","18.4","Q1","2.02","31.94"%,
"PROGRESS IN RETINAL AND EYE RESEARCH","PROG RETIN EYE RES","1350-9462","1873-1635","OPHTHALMOLOGY - SCIE","11,451","17.8","Q1","4.32","28.76"%,
"Cancer Communications","CANCER COMMUN","N/A","2523-3548","ONCOLOGY - SCIE","3,572","16.2","Q1","2.38","62.29"%,
"NEURO-ONCOLOGY","NEURO-ONCOLOGY","1522-8517","1523-5866","ONCOLOGY - SCIE","22,890","15.9","Q1","3.22","27.8"%,
"SEMINARS IN CANCER BIOLOGY","SEMIN CANCER BIOL","1044-579X","1096-3650","ONCOLOGY - SCIE","17,307","14.5","Q1","2.45","19.13"%,
"Liver Cancer","LIVER CANCER","2235-1795","1664-5553","ONCOLOGY - SCIE","2,842","13.8","Q1","2.35","100"%,
"OPHTHALMOLOGY","OPHTHALMOLOGY","0161-6420","1549-4713","OPHTHALMOLOGY - SCIE","47,448","13.7","Q1","4.96","26.02"%,
"Journal of the National Comprehensive Cancer Network","J NATL COMPR CANC NE","1540-1405","1540-1413","ONCOLOGY - SCIE","12,716","13.4","Q1","2.35","0.23"%,
"Blood Cancer Journal","BLOOD CANCER J","2044-5385","2044-5385","ONCOLOGY - SCIE","6,523","12.8","Q1","1.91","99.66"%,
"TECHNOVATION","TECHNOVATION","0166-4972","1879-2383","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","10,085","12.5","Q1","2.13","23.97"%,
"JOURNAL OF MANUFACTURING SYSTEMS","J MANUF SYST","0278-6125","1878-6642","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","10,303","12.1","Q1","2.15","15.21"%,
"INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS","INT J PROD ECON","0925-5273","1873-7579","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","37,217","12","Q1","2.14","13.01"%,
"CANCER TREATMENT REVIEWS","CANCER TREAT REV","0305-7372","1532-1967","ONCOLOGY - SCIE","12,849","11.8","Q1","1.51","34.42"%,
"CLINICAL CANCER RESEARCH","CLIN CANCER RES","1078-0432","1557-3265","ONCOLOGY - SCIE","105,188","11.5","Q1","2.53","18.47"%,
"Blood Cancer Discovery","BLOOD CANCER DISCOV","2643-3230","2643-3249","ONCOLOGY - ESCI","794","11.4","N/A","2.18","23.86"%,
"LEUKEMIA","LEUKEMIA","0887-6924","1476-5551","ONCOLOGY - SCIE","33,595","11.4","Q1","1.99","43.66"%,
"Experimental Hematology & Oncology","EXP HEMATOL ONCOL","N/A","2162-3619","ONCOLOGY - SCIE","1,706","11.4","Q1","1.46","100"%,
"JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH","J EXP CLIN CANC RES","N/A","1756-9966","ONCOLOGY - SCIE","23,460","11.3","Q1","2.06","99.66"%,
"CANCER RESEARCH","CANCER RES","0008-5472","1538-7445","ONCOLOGY - SCIE","141,481","11.2","Q1","1.93","15.18"%,
"BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER","BBA-REV CANCER","0304-419X","1879-2561","ONCOLOGY - SCIE","9,303","11.2","Q1","1.36","22.19"%,
"JACC: CardioOncology","JACC-CARDIOONCOL","2666-0873","2666-0873","ONCOLOGY - SCIE","1,345","11.1","Q1","1.66","89.05"%,
"Biomarker Research","BIOMARK RES","N/A","2050-7771","ONCOLOGY - SCIE","2,839","11.1","Q1","1.45","100"%,
"Journal for ImmunoTherapy of Cancer","J IMMUNOTHER CANCER","N/A","2051-1426","ONCOLOGY - SCIE","23,254","10.9","Q1","1.9","99.81"%,
"TRANSPORTATION RESEARCH PART E-LOGISTICS AND TRANSPORTATION REVIEW","TRANSPORT RES E-LOG","1366-5545","1878-5794","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","17,072","10.6","Q1","2.32","9.33"%,
"Clinical and Translational Medicine","CLIN TRANSL MED","2001-1326","2001-1326","ONCOLOGY - SCIE","5,458","10.6","Q1","1.62","59.71"%,
"JNCI-Journal of the National Cancer Institute","JNCI-J NATL CANCER I","0027-8874","1460-2105","ONCOLOGY - SCIE","38,065","10.3","Q1","2.37","26.46"%,
"Cancer Immunology Research","CANCER IMMUNOL RES","2326-6066","2326-6074","ONCOLOGY - SCIE","12,883","10.1","Q1","2.07","15.23"%,
"CANCER LETTERS","CANCER LETT","0304-3835","1872-7980","ONCOLOGY - SCIE","43,634","9.7","Q1","1.83","24.39"%,
"INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH","INT J PROD RES","0020-7543","1366-588X","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","37,041","9.2","Q1","1.46","7.79"%,
"CANCER AND METASTASIS REVIEWS","CANCER METAST REV","0167-7659","1573-7233","ONCOLOGY - SCIE","8,081","9.2","Q1","1.07","39.36"%,
"BRITISH JOURNAL OF CANCER","BRIT J CANCER","0007-0920","1532-1827","ONCOLOGY - SCIE","53,689","8.8","Q1","1.44","70.33"%,
"EXPERT SYSTEMS WITH APPLICATIONS","EXPERT SYST APPL","0957-4174","1873-6793","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","76,302","8.5","Q1","1.73","7.57"%,
"EUROPEAN JOURNAL OF CANCER","EUR J CANCER","0959-8049","1879-0852","ONCOLOGY - SCIE","40,311","8.4","Q1","1.68","38.42"%,
"PRODUCTION PLANNING & CONTROL","PROD PLAN CONTROL","0953-7287","1366-5871","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","7,530","8.3","Q1","1.15","15.62"%,
"European Urology Oncology","EUR UROL ONCOL","N/A","2588-9311","ONCOLOGY - SCIE","2,742","8.2","Q1","2.12","14.29"%,
"JAMA Ophthalmology","JAMA OPHTHALMOL","2168-6165","2168-6173","OPHTHALMOLOGY - SCIE","9,926","8.1","Q1","3.05","14.92"%,
"RELIABILITY ENGINEERING & SYSTEM SAFETY","RELIAB ENG SYST SAFE","0951-8320","1879-0836","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","30,065","8.1","Q1","1.48","15.05"%,
"Frontiers of Medicine","FRONT MED-PRC","2095-0217","2095-0225","ONCOLOGY - SCIE","3,240","8.1","Q1","0.84","13.62"%,
"ONCOGENE","ONCOGENE","0950-9232","1476-5594","ONCOLOGY - SCIE","74,751","8","Q1","1.56","34.41"%,
"npj Precision Oncology","NPJ PRECIS ONCOL","N/A","2397-768X","ONCOLOGY - SCIE","2,147","7.9","Q1","1.54","99.56"%,
"JOURNAL OF OPERATIONS MANAGEMENT","J OPER MANAG","0272-6963","1873-1317","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","12,815","7.8","Q1","1.37","17.04"%,
"Annual Review of Cancer Biology","ANNU REV CANCER BIOL","2472-3428","2472-3428","ONCOLOGY - SCIE","1,068","7.7","Q1","2.05","77.05"%,
"DECISION SUPPORT SYSTEMS","DECIS SUPPORT SYST","0167-9236","1873-5797","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","14,918","7.5","Q1","1.36","13.6"%,
"Gastric Cancer","GASTRIC CANCER","1436-3291","1436-3305","ONCOLOGY - SCIE","8,143","7.4","Q1","1.45","26.76"%,
"BREAST CANCER RESEARCH","BREAST CANCER RES","1465-5411","1465-542X","ONCOLOGY - SCIE","13,562","7.4","Q1","1.33","99.39"%,
"JOURNAL OF PATHOLOGY","J PATHOL","0022-3417","1096-9896","ONCOLOGY - SCIE","19,948","7.3","Q1","1.81","33.59"%,
"ESMO Open","ESMO OPEN","N/A","2059-7029","ONCOLOGY - SCIE","5,085","7.3","Q1","1.2","90.74"%,
"OncoImmunology","ONCOIMMUNOLOGY","2162-402X","2162-402X","ONCOLOGY - SCIE","16,708","7.2","Q1","1.24","100"%,
"INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS","INT J RADIAT ONCOL","0360-3016","1879-355X","ONCOLOGY - SCIE","46,275","7","Q1","1.57","16.54"%,
"OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE","OMEGA-INT J MANAGE S","0305-0483","1873-5274","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","14,646","6.9","Q1","1.89","13.84"%,
"TRANSPORTATION RESEARCH PART B-METHODOLOGICAL","TRANSPORT RES B-METH","0191-2615","1879-2367","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","18,547","6.8","Q1","1.66","19.56"%,
"BIODRUGS","BIODRUGS","1173-8804","1179-190X","ONCOLOGY - SCIE","2,991","6.8","Q1","1.05","49.7"%,
"Oncolytic Virotherapy","ONCOLYTIC VIROTHER","2253-1572","2253-1572","ONCOLOGY - ESCI","190","6.7","N/A","0.69","100"%,
"Journal of Management Science and Engineering","J MANAGE SCI ENG","2096-2320","2589-5532","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","503","6.6","N/A","1.72","94.05"%,
"CELLULAR ONCOLOGY","CELL ONCOL","2211-3428","2211-3436","ONCOLOGY - SCIE","3,107","6.6","Q1","1.25","27.7"%,
"Molecular Oncology","MOL ONCOL","1574-7891","1878-0261","ONCOLOGY - SCIE","10,372","6.6","Q1","1.23","99.1"%,
"Ocular Surface","OCUL SURF","1542-0124","1937-5913","OPHTHALMOLOGY - SCIE","6,053","6.4","Q1","2.47","23.05"%,
"EUROPEAN JOURNAL OF OPERATIONAL RESEARCH","EUR J OPER RES","0377-2217","1872-6860","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","70,097","6.4","Q1","1.44","19.21"%,
"INTERNATIONAL JOURNAL OF CANCER","INT J CANCER","0020-7136","1097-0215","ONCOLOGY - SCIE","57,621","6.4","Q1","1.33","32.2"%,
"CANCER GENE THERAPY","CANCER GENE THER","0929-1903","1476-5500","ONCOLOGY - SCIE","4,880","6.4","Q1","1.24","28.27"%,
"Mathematical Programming Computation","MATH PROGRAM COMPUT","1867-2949","1867-2957","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,614","6.3","Q1","3.19","36.92"%,
"M&SOM-Manufacturing & Service Operations Management","M&SOM-MANUF SERV OP","1523-4614","1526-5498","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","6,977","6.3","Q1","1.34","0"%,
"CANCER","CANCER-AM CANCER SOC","0008-543X","1097-0142","ONCOLOGY - SCIE","71,863","6.2","Q1","1.41","10.66"%,
"Oncogenesis","ONCOGENESIS","2157-9024","2157-9024","ONCOLOGY - SCIE","4,453","6.2","Q1","1.28","99.17"%,
"CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY","CRIT REV ONCOL HEMAT","1040-8428","1879-0461","ONCOLOGY - SCIE","11,865","6.2","Q1","0.88","15.55"%,
"SOCIO-ECONOMIC PLANNING SCIENCES","SOCIO-ECON PLAN SCI","0038-0121","1873-6041","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","4,641","6.1","Q1","1.53","7.41"%,
"SAFETY SCIENCE","SAFETY SCI","0925-7535","1879-1042","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","22,125","6.1","Q1","1.1","17.88"%,
"Annual Review of Vision Science","ANNU REV VIS SCI","2374-4642","2374-4650","OPHTHALMOLOGY - SCIE","1,446","6","Q1","0.97","0"%,
"npj Breast Cancer","NPJ BREAST CANCER","N/A","2374-4677","ONCOLOGY - SCIE","2,586","5.9","Q1","1.22","100"%,
"Cancer & Metabolism","CANCER METAB","N/A","2049-3002","ONCOLOGY - SCIE","1,436","5.9","Q1","0.98","100"%,
"Cancer Cell International","CANCER CELL INT","N/A","1475-2867","ONCOLOGY - SCIE","13,551","5.8","Q1","1.12","99.64"%,
"CANCER IMMUNOLOGY IMMUNOTHERAPY","CANCER IMMUNOL IMMUN","0340-7004","1432-0851","ONCOLOGY - SCIE","13,315","5.8","Q1","1.06","32.52"%,
"ONCOLOGIST","ONCOLOGIST","1083-7159","1549-490X","ONCOLOGY - SCIE","18,441","5.8","Q1","1","49.65"%,
"RADIOTHERAPY AND ONCOLOGY","RADIOTHER ONCOL","0167-8140","1879-0887","ONCOLOGY - SCIE","23,221","5.7","Q2","1.42","28.05"%,
"Clinical Epigenetics","CLIN EPIGENETICS","1868-7075","1868-7083","ONCOLOGY - SCIE","7,724","5.7","Q2","1.25","99.3"%,
"Molecular Therapy-Oncolytics","MOL THER-ONCOLYTICS","2372-7705","2372-7705","ONCOLOGY - SCIE","3,412","5.7","Q2","1.22","89.58"%,
"MOLECULAR CANCER THERAPEUTICS","MOL CANCER THER","1535-7163","1538-8514","ONCOLOGY - SCIE","22,301","5.7","Q2","1.16","17.95"%,
"CANCER SCIENCE","CANCER SCI","1347-9032","1349-7006","ONCOLOGY - SCIE","20,941","5.7","Q2","1.09","72.21"%,
"Cancer Nanotechnology","CANCER NANOTECHNOL","1868-6958","1868-6966","ONCOLOGY - SCIE","866","5.7","Q2","0.92","100"%,
"Cancer Biology & Medicine","CANCER BIOL MED","2095-3941","2095-3941","ONCOLOGY - SCIE","3,145","5.5","Q2","0.88","92.75"%,
"Sustainable Futures","SUSTAIN FUTURES","2666-1888","2666-1888","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","288","5.5","N/A","0.63","98.78"%,
"MANAGEMENT SCIENCE","MANAGE SCI","0025-1909","1526-5501","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","51,695","5.4","Q1","1.19","0"%,
"Targeted Oncology","TARGET ONCOL","1776-2596","1776-260X","ONCOLOGY - SCIE","2,401","5.4","Q2","0.92","42.79"%,
"LUNG CANCER","LUNG CANCER","0169-5002","1872-8332","ONCOLOGY - SCIE","16,050","5.3","Q2","1.17","28.15"%,
"American Journal of Cancer Research","AM J CANCER RES","2156-6976","2156-6976","ONCOLOGY - SCIE","10,201","5.3","Q2","0.9","0"%,
"World Journal of Oncology","WORLD J ONCOL","1920-4531","1920-454X","ONCOLOGY - ESCI","1,372","5.2","N/A","1.34","97.12"%,
"INTERNATIONAL JOURNAL OF ONCOLOGY","INT J ONCOL","1019-6439","1791-2423","ONCOLOGY - SCIE","20,086","5.2","Q2","0.99","65.98"%,
"STEM CELLS","STEM CELLS","1066-5099","1549-4918","ONCOLOGY - SCIE","18,981","5.2","Q2","0.98","34.79"%,
"MOLECULAR CANCER RESEARCH","MOL CANCER RES","1541-7786","1557-3125","ONCOLOGY - SCIE","11,324","5.2","Q2","0.94","12.82"%,
"Cancers","CANCERS","N/A","2072-6694","ONCOLOGY - SCIE","81,774","5.2","Q2","0.93","99.37"%,
"SURVEY OF OPHTHALMOLOGY","SURV OPHTHALMOL","0039-6257","1879-3304","OPHTHALMOLOGY - SCIE","7,561","5.1","Q1","1.21","6.61"%,
"NAR Cancer","NAR CANCER","2632-8674","2632-8674","ONCOLOGY - ESCI","469","5.1","N/A","0.68","73.64"%,
"Chinese Journal of Cancer Research","CHINESE J CANCER RES","1000-9604","1993-0631","ONCOLOGY - SCIE","2,725","5.1","Q2","0.66","98.86"%,
"Translational Oncology","TRANSL ONCOL","1936-5233","1936-5233","ONCOLOGY - SCIE","6,238","5","Q2","1.01","96.88"%,
"PRODUCTION AND OPERATIONS MANAGEMENT","PROD OPER MANAG","1059-1478","1937-5956","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","12,580","5","Q1","0.94","11.28"%,
"Hepatic Oncology","HEPAT ONCOL","2045-0923","2045-0931","ONCOLOGY - ESCI","300","5","N/A","0.6","100"%,
"CANCER IMAGING","CANCER IMAGING","1740-5025","1470-7330","ONCOLOGY - SCIE","2,779","4.9","Q2","1.06","100"%,
"Therapeutic Advances in Medical Oncology","THER ADV MED ONCOL","1758-8340","1758-8359","ONCOLOGY - SCIE","4,469","4.9","Q2","0.83","94.58"%,
"INTERNATIONAL JOURNAL OF INFORMATION TECHNOLOGY & DECISION MAKING","INT J INF TECH DECIS","0219-6220","1793-6845","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,948","4.9","Q1","0.8","1.65"%,
"ORAL ONCOLOGY","ORAL ONCOL","1368-8375","1879-0593","ONCOLOGY - SCIE","13,846","4.8","Q2","1.25","14.48"%,
"INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER","INT J GYNECOL CANCER","1048-891X","1525-1438","ONCOLOGY - SCIE","10,029","4.8","Q2","1.22","8.93"%,
"PROSTATE CANCER AND PROSTATIC DISEASES","PROSTATE CANCER P D","1365-7852","1476-5608","ONCOLOGY - SCIE","3,968","4.8","Q2","1.17","25.38"%,
"NEOPLASIA","NEOPLASIA","1476-5586","1476-5586","ONCOLOGY - SCIE","9,293","4.8","Q2","1.05","97.06"%,
"ANNALS OF OPERATIONS RESEARCH","ANN OPER RES","0254-5330","1572-9338","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","17,866","4.8","Q1","1","16.25"%,
"International Journal of Management Science and Engineering Management","INT J MANAG SCI ENG","1750-9653","1750-9661","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","919","4.8","N/A","0.94","2.8"%,
"BONE MARROW TRANSPLANTATION","BONE MARROW TRANSPL","0268-3369","1476-5365","ONCOLOGY - SCIE","15,725","4.8","Q2","0.88","17.76"%,
"Gynecologic Oncology","GYNECOL ONCOL","0090-8258","1095-6859","ONCOLOGY - SCIE","28,267","4.7","Q2","1.35","19.59"%,
"CARCINOGENESIS","CARCINOGENESIS","0143-3334","1460-2180","ONCOLOGY - SCIE","18,766","4.7","Q2","0.94","14.39"%,
"Fuzzy Optimization and Decision Making","FUZZY OPTIM DECIS MA","1568-4539","1573-2908","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,396","4.7","Q2","0.9","6.45"%,
"Frontiers in Oncology","FRONT ONCOL","2234-943X","2234-943X","ONCOLOGY - SCIE","68,053","4.7","Q2","0.83","99.42"%,
"Memetic Computing","MEMET COMPUT","1865-9284","1865-9292","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,074","4.7","Q2","0.8","7.95"%,
"Current Oncology Reports","CURR ONCOL REP","1523-3790","1534-6269","ONCOLOGY - SCIE","4,455","4.7","Q2","0.67","18.08"%,
"TRANSPORTATION SCIENCE","TRANSPORT SCI","0041-1655","N/A","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","8,143","4.6","Q2","1","0"%,
"Cancer Research and Treatment","CANCER RES TREAT","1598-2998","2005-9256","ONCOLOGY - SCIE","4,229","4.6","Q2","0.97","95.81"%,
"COMPUTERS & OPERATIONS RESEARCH","COMPUT OPER RES","0305-0548","1873-765X","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","18,281","4.6","Q2","0.88","15.48"%,
"JCO Precision Oncology","JCO PRECIS ONCOL","N/A","2473-4284","ONCOLOGY - SCIE","4,273","4.6","Q2","0.85","35.96"%,
"MOLECULAR CARCINOGENESIS","MOL CARCINOGEN","0899-1987","1098-2744","ONCOLOGY - SCIE","6,760","4.6","Q2","0.85","8.41"%,
"Ophthalmology Retina","OPHTHALMOL RETINA","2468-6530","N/A","OPHTHALMOLOGY - ESCI","2,803","4.5","N/A","1.95","21.02"%,
"JCO Global Oncology","JCO GLOB ONCOL","N/A","2687-8941","ONCOLOGY - ESCI","1,674","4.5","N/A","0.8","94"%,
"INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE","INVEST OPHTH VIS SCI","0146-0404","1552-5783","OPHTHALMOLOGY - SCIE","59,396","4.4","Q1","1.57","99.48"%,
"IEEE Systems Journal","IEEE SYST J","1932-8184","1937-9234","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","13,413","4.4","Q2","1.15","4.57"%,
"Eye and Brain","EYE BRAIN","1179-2744","1179-2744","OPHTHALMOLOGY - ESCI","491","4.4","N/A","1.12","95.45"%,
"JNCI Cancer Spectrum","JNCI CANCER SPECT","N/A","2515-5091","ONCOLOGY - ESCI","1,655","4.4","N/A","0.84","95.1"%,
"Radiology-Imaging Cancer","RADIOL-IMAG CANCER","2638-616X","2638-616X","ONCOLOGY - ESCI","342","4.4","N/A","0.69","100"%,
"Asia-Pacific Journal of Ophthalmology","ASIA-PAC J OPHTHALMO","N/A","2162-0989","OPHTHALMOLOGY - SCIE","1,875","4.3","Q1","0.96","97.92"%,
"Pigment Cell & Melanoma Research","PIGM CELL MELANOMA R","1755-1471","1755-148X","ONCOLOGY - SCIE","5,153","4.3","Q2","0.86","19.58"%,
"INTERNATIONAL JOURNAL OF SYSTEMS SCIENCE","INT J SYST SCI","0020-7721","1464-5319","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","7,082","4.3","Q2","0.8","2.79"%,
"CURRENT TREATMENT OPTIONS IN ONCOLOGY","CURR TREAT OPTION ON","1527-2729","1534-6277","ONCOLOGY - SCIE","3,162","4.3","Q2","0.6","14.16"%,
"AMERICAN JOURNAL OF OPHTHALMOLOGY","AM J OPHTHALMOL","0002-9394","1879-1891","OPHTHALMOLOGY - SCIE","30,880","4.2","Q1","2.07","17.15"%,
"Eye and Vision","EYE VISION","2326-0254","2326-0254","OPHTHALMOLOGY - SCIE","1,208","4.2","Q1","1.44","100"%,
"International Journal of Systems Science-Operations & Logistics","INT J SYST SCI-OPER","2330-2674","2330-2682","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","708","4.2","Q2","1.44","0.74"%,
"CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE","CAN J OPHTHALMOL","0008-4182","1715-3360","OPHTHALMOLOGY - SCIE","3,065","4.2","Q1","0.79","3.82"%,
"JCO Clinical Cancer Informatics","JCO CLIN CANCER INFO","2473-4276","2473-4276","ONCOLOGY - ESCI","1,748","4.2","N/A","0.78","37.37"%,
"ONCOLOGY REPORTS","ONCOL REP","1021-335X","1791-2431","ONCOLOGY - SCIE","25,112","4.2","Q2","0.78","71.89"%,
"Prostate Cancer","PROSTATE CANCER","2090-3111","2090-312X","ONCOLOGY - ESCI","386","4.2","N/A","0.29","100"%,
"Colorectal Cancer","COLORECTAL CANCER","1758-194X","1758-1958","ONCOLOGY - ESCI","169","4.2","N/A","0.28","83.33"%,
"BRITISH JOURNAL OF OPHTHALMOLOGY","BRIT J OPHTHALMOL","0007-1161","1468-2079","OPHTHALMOLOGY - SCIE","26,382","4.1","Q1","1.93","20.56"%,
"INTERNATIONAL JOURNAL OF COMPUTER INTEGRATED MANUFACTURING","INT J COMPUT INTEG M","0951-192X","1362-3052","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,247","4.1","Q2","0.8","12.59"%,
"Journal of Hepatocellular Carcinoma","J HEPATOCELL CARCINO","N/A","2253-5969","ONCOLOGY - SCIE","1,171","4.1","Q2","0.76","89.29"%,
"CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY","CLIN EXP OPHTHALMOL","1442-6404","1442-9071","OPHTHALMOLOGY - SCIE","5,127","4","Q1","1.21","12.61"%,
"Breast Cancer","BREAST CANCER-TOKYO","1340-6868","1880-4233","ONCOLOGY - SCIE","3,598","4","Q2","0.87","26.57"%,
"Translational Lung Cancer Research","TRANSL LUNG CANCER R","2218-6751","2226-4477","ONCOLOGY - SCIE","5,436","4","Q2","0.81","99.35"%,
"OncoTargets and Therapy","ONCOTARGETS THER","1178-6930","1178-6930","ONCOLOGY - SCIE","19,263","4","Q2","0.78","97.88"%,
"Cancer Medicine","CANCER MED-US","2045-7634","2045-7634","ONCOLOGY - SCIE","18,374","4","Q2","0.77","68.75"%,
"CLINICAL & EXPERIMENTAL METASTASIS","CLIN EXP METASTAS","0262-0898","1573-7276","ONCOLOGY - SCIE","3,900","4","Q2","0.72","33.52"%,
"JCO Oncology Practice","JCO ONCOL PRACT","2688-1527","2688-1535","ONCOLOGY - SCIE","2,306","4","Q2","0.69","8.06"%,
"SEMINARS IN ONCOLOGY","SEMIN ONCOL","0093-7754","1532-8708","ONCOLOGY - SCIE","5,227","4","Q2","0.55","11.19"%,
"Journal of Gynecologic Oncology","J GYNECOL ONCOL","2005-0380","2005-0399","ONCOLOGY - SCIE","2,593","3.9","Q2","1.22","99.02"%,
"BREAST","BREAST","0960-9776","1532-3080","ONCOLOGY - SCIE","6,969","3.9","Q2","1.12","90.59"%,
"EYE","EYE","0950-222X","1476-5454","OPHTHALMOLOGY - SCIE","15,578","3.9","Q1","1.12","19.94"%,
"JOURNAL OF NEURO-ONCOLOGY","J NEURO-ONCOL","0167-594X","1573-7373","ONCOLOGY - SCIE","15,608","3.9","Q2","0.9","19.11"%,
"ENDOCRINE-RELATED CANCER","ENDOCR-RELAT CANCER","1351-0088","1479-6821","ONCOLOGY - SCIE","8,046","3.9","Q2","0.88","14.23"%,
"JOURNAL OF IMMUNOTHERAPY","J IMMUNOTHER","1524-9557","1537-4513","ONCOLOGY - SCIE","3,707","3.9","Q2","0.85","18.92"%,
"Journal of Cancer","J CANCER","1837-9664","1837-9664","ONCOLOGY - SCIE","14,669","3.9","Q2","0.77","99.72"%,
"EJSO","EJSO-EUR J SURG ONC","0748-7983","1532-2157","ONCOLOGY - SCIE","13,305","3.8","Q2","1.18","18.94"%,
"CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION","CANCER EPIDEM BIOMAR","1055-9965","1538-7755","ONCOLOGY - SCIE","21,437","3.8","Q2","0.94","10.16"%,
"BMC CANCER","BMC CANCER","N/A","1471-2407","ONCOLOGY - SCIE","46,702","3.8","Q2","0.78","99.46"%,
"Logistics-Basel","LOGISTICS-BASEL","N/A","2305-6290","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","807","3.8","N/A","0.76","98.54"%,
"BREAST CANCER RESEARCH AND TREATMENT","BREAST CANCER RES TR","0167-6806","1573-7217","ONCOLOGY - SCIE","25,242","3.8","Q2","0.75","26.55"%,
"ANNALS OF SURGICAL ONCOLOGY","ANN SURG ONCOL","1068-9265","1534-4681","ONCOLOGY - SCIE","36,703","3.7","Q2","1.23","13.34"%,
"Journal of Cancer Survivorship","J CANCER SURVIV","1932-2259","1932-2267","ONCOLOGY - SCIE","4,701","3.7","Q2","0.82","25.79"%,
"CURRENT OPINION IN OPHTHALMOLOGY","CURR OPIN OPHTHALMOL","1040-8738","1531-7021","OPHTHALMOLOGY - SCIE","4,739","3.7","Q1","0.81","3.8"%,
"GENES CHROMOSOMES & CANCER","GENE CHROMOSOME CANC","1045-2257","1098-2264","ONCOLOGY - SCIE","5,511","3.7","Q2","0.78","21.11"%,
"Physics & Imaging in Radiation Oncology","PHYS IMAG RADIAT ONC","N/A","2405-6316","ONCOLOGY - ESCI","930","3.7","N/A","0.76","93.33"%,
"EXPERIMENTAL CELL RESEARCH","EXP CELL RES","0014-4827","1090-2422","ONCOLOGY - SCIE","22,952","3.7","Q2","0.64","16.68"%,
"Infectious Agents and Cancer","INFECT AGENTS CANCER","1750-9378","1750-9378","ONCOLOGY - SCIE","1,789","3.7","Q2","0.62","100"%,
"Cancer Drug Resistance","CANCER DRUG RESIST","N/A","2578-532X","ONCOLOGY - ESCI","917","3.7","N/A","0.44","99.49"%,
"Radiation Oncology","RADIAT ONCOL","N/A","1748-717X","ONCOLOGY - SCIE","8,845","3.6","Q2","0.83","99.86"%,
"Clinical Lung Cancer","CLIN LUNG CANCER","1525-7304","1938-0690","ONCOLOGY - SCIE","4,672","3.6","Q2","0.81","19.14"%,
"PSYCHO-ONCOLOGY","PSYCHO-ONCOLOGY","1057-9249","1099-1611","ONCOLOGY - SCIE","15,362","3.6","Q2","0.8","18.84"%,
"CANCER BIOLOGY & THERAPY","CANCER BIOL THER","1538-4047","1555-8576","ONCOLOGY - SCIE","8,887","3.6","Q2","0.78","42.8"%,
"JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY","J CANCER RES CLIN","0171-5216","1432-1335","ONCOLOGY - SCIE","11,329","3.6","Q2","0.71","36.6"%,
"JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY","J OPER RES SOC","0160-5682","1476-9360","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","12,363","3.6","Q2","0.65","6.12"%,
"Lung Cancer-Targets and Therapy","LUNG CANCER-TARGETS","N/A","1179-2728","ONCOLOGY - ESCI","393","3.6","N/A","0.56","93.55"%,
"Oncology Reviews","ONCOL REV","1970-5557","1970-5565","ONCOLOGY - ESCI","762","3.6","N/A","0.44","100"%,
"Melanoma Management","MELANOMA MANAG","2045-0885","2045-0893","ONCOLOGY - ESCI","254","3.6","N/A","0.37","94.44"%,
"SEMINARS IN RADIATION ONCOLOGY","SEMIN RADIAT ONCOL","1053-4296","1532-9461","ONCOLOGY - SCIE","2,801","3.5","Q3","1.05","9.16"%,
"ONCOLOGY","ONCOLOGY-BASEL","0030-2414","1423-0232","ONCOLOGY - SCIE","4,917","3.5","Q3","0.61","14.24"%,
"Neuro-Oncology Advances","NEURO-ONCOL ADV","N/A","2632-2498","ONCOLOGY - ESCI","1,494","3.5","N/A","0.59","96.53"%,
"EXPERIMENTAL EYE RESEARCH","EXP EYE RES","0014-4835","1096-0007","OPHTHALMOLOGY - SCIE","15,905","3.4","Q2","1.47","20.6"%,
"ACTA OPHTHALMOLOGICA","ACTA OPHTHALMOL","1755-375X","1755-3768","OPHTHALMOLOGY - SCIE","12,169","3.4","Q2","1.11","29.82"%,
"CANCER CYTOPATHOLOGY","CANCER CYTOPATHOL","1934-662X","1934-6638","ONCOLOGY - SCIE","3,190","3.4","Q3","0.87","10.21"%,
"INVESTIGATIONAL NEW DRUGS","INVEST NEW DRUG","0167-6997","1573-0646","ONCOLOGY - SCIE","5,844","3.4","Q3","0.86","25.62"%,
"CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS","CANCER BIOTHER RADIO","1084-9785","1557-8852","ONCOLOGY - SCIE","2,857","3.4","Q3","0.77","5.12"%,
"Clinical Colorectal Cancer","CLIN COLORECTAL CANC","1533-0028","1938-0674","ONCOLOGY - SCIE","2,528","3.4","Q3","0.71","14.72"%,
"Journal of Bone Oncology","J BONE ONCOL","N/A","2212-1374","ONCOLOGY - SCIE","1,356","3.4","Q3","0.71","96.61"%,
"Molecular Medicine Reports","MOL MED REP","1791-2997","1791-3004","ONCOLOGY - SCIE","31,143","3.4","Q3","0.71","84.28"%,
"CLINICAL ONCOLOGY","CLIN ONCOL-UK","0936-6555","1433-2981","ONCOLOGY - SCIE","4,665","3.4","Q3","0.69","18.78"%,
"MEDICAL ONCOLOGY","MED ONCOL","1357-0560","1559-131X","ONCOLOGY - SCIE","7,095","3.4","Q3","0.65","13.06"%,
"Clinical & Translational Oncology","CLIN TRANSL ONCOL","1699-048X","1699-3055","ONCOLOGY - SCIE","5,242","3.4","Q3","0.62","17.92"%,
"Journal of Decision Systems","J DECIS SYST","1246-0125","2116-7052","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","869","3.4","N/A","0.58","10.84"%,
"CURRENT OPINION IN ONCOLOGY","CURR OPIN ONCOL","1040-8746","1531-703X","ONCOLOGY - SCIE","3,171","3.4","Q3","0.44","8.58"%,
"RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES","RETINA-J RET VIT DIS","0275-004X","1539-2864","OPHTHALMOLOGY - SCIE","14,203","3.3","Q2","1.48","11.9"%,
"Ophthalmology and Therapy","OPHTHALMOL THER","2193-8245","2193-6528","OPHTHALMOLOGY - SCIE","1,321","3.3","Q2","1.01","99.73"%,
"OCULAR IMMUNOLOGY AND INFLAMMATION","OCUL IMMUNOL INFLAMM","0927-3948","1744-5078","OPHTHALMOLOGY - SCIE","5,334","3.3","Q2","0.99","4.22"%,
"Practical Radiation Oncology","PRACT RADIAT ONCOL","1879-8500","1879-8500","ONCOLOGY - SCIE","2,793","3.3","Q3","0.79","8.72"%,
"Brain Tumor Pathology","BRAIN TUMOR PATHOL","1433-7398","1861-387X","ONCOLOGY - SCIE","966","3.3","Q3","0.68","6.17"%,
"Cardio-Oncology","CARDIO-ONCOLOGY","N/A","2057-3804","ONCOLOGY - ESCI","436","3.3","N/A","0.67","100"%,
"Cancer Prevention Research","CANCER PREV RES","1940-6207","1940-6215","ONCOLOGY - SCIE","5,720","3.3","Q3","0.66","8.25"%,
"Photodiagnosis and Photodynamic Therapy","PHOTODIAGN PHOTODYN","1572-1000","1873-1597","ONCOLOGY - SCIE","7,474","3.3","Q3","0.65","5.14"%,
"Cancer Management and Research","CANCER MANAG RES","1179-1322","1179-1322","ONCOLOGY - SCIE","13,689","3.3","Q3","0.63","97.36"%,
"International Journal of Clinical Oncology","INT J CLIN ONCOL","1341-9625","1437-7772","ONCOLOGY - SCIE","5,463","3.3","Q3","0.63","17.47"%,
"HEMATOLOGICAL ONCOLOGY","HEMATOL ONCOL","0278-0232","1099-1069","ONCOLOGY - SCIE","2,319","3.3","Q3","0.57","17.04"%,
"Future Oncology","FUTURE ONCOL","1479-6694","1744-8301","ONCOLOGY - SCIE","8,035","3.3","Q3","0.56","38.1"%,
"International Journal of Industrial Engineering Computations","INT J IND ENG COMP","1923-2926","1923-2934","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,250","3.3","Q2","0.55","96.72"%,
"CHEMOTHERAPY","CHEMOTHERAPY","0009-3157","1421-9794","ONCOLOGY - SCIE","1,657","3.3","Q3","0.54","4.9"%,
"Expert Review of Anticancer Therapy","EXPERT REV ANTICANC","1473-7140","1744-8328","ONCOLOGY - SCIE","4,425","3.3","Q3","0.45","9.17"%,
"Contact Lens & Anterior Eye","CONTACT LENS ANTERIO","1367-0484","1476-5411","OPHTHALMOLOGY - SCIE","2,838","3.2","Q2","1.38","12.06"%,
"World Journal of Surgical Oncology","WORLD J SURG ONCOL","N/A","1477-7819","ONCOLOGY - SCIE","8,671","3.2","Q3","0.99","99.81"%,
"Clinical Genitourinary Cancer","CLIN GENITOURIN CANC","1558-7673","1938-0682","ONCOLOGY - SCIE","3,509","3.2","Q3","0.81","13.08"%,
"JOURNAL OF NEURO-OPHTHALMOLOGY","J NEURO-OPHTHALMOL","1070-8022","1536-5166","OPHTHALMOLOGY - SCIE","2,761","3.2","Q2","0.8","4.39"%,
"PEDIATRIC BLOOD & CANCER","PEDIATR BLOOD CANCER","1545-5009","1545-5017","ONCOLOGY - SCIE","16,460","3.2","Q3","0.7","10.14"%,
"Analytical Cellular Pathology","ANAL CELL PATHOL","2210-7177","2210-7185","ONCOLOGY - SCIE","1,127","3.2","Q3","0.6","100"%,
"INDIAN JOURNAL OF OPHTHALMOLOGY","INDIAN J OPHTHALMOL","0301-4738","1998-3689","OPHTHALMOLOGY - SCIE","8,648","3.1","Q2","1.04","99.03"%,
"SUPPORTIVE CARE IN CANCER","SUPPORT CARE CANCER","0941-4355","1433-7339","ONCOLOGY - SCIE","21,042","3.1","Q3","0.94","21.05"%,
"Clinical and Translational Radiation Oncology","CLIN TRANSL RAD ONCO","N/A","2405-6308","ONCOLOGY - SCIE","1,540","3.1","Q3","0.88","92.38"%,
"INTERNATIONAL JOURNAL OF HYPERTHERMIA","INT J HYPERTHER","0265-6736","1464-5157","ONCOLOGY - SCIE","6,456","3.1","Q3","0.8","97.68"%,
"International Transactions in Operational Research","INT T OPER RES","0969-6016","1475-3995","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,607","3.1","Q2","0.8","6.09"%,
"ONCOLOGY RESEARCH","ONCOL RES","0965-0407","1555-3906","ONCOLOGY - SCIE","2,942","3.1","Q3","0.75","98.45"%,
"Cancer Biomarkers","CANCER BIOMARK","1574-0153","1875-8592","ONCOLOGY - SCIE","3,701","3.1","Q3","0.71","5.37"%,
"STRAHLENTHERAPIE UND ONKOLOGIE","STRAHLENTHER ONKOL","0179-7158","1439-099X","ONCOLOGY - SCIE","3,580","3.1","Q3","0.7","50"%,
"Clinical Breast Cancer","CLIN BREAST CANCER","1526-8209","1938-0666","ONCOLOGY - SCIE","4,253","3.1","Q3","0.61","11.51"%,
"ACTA ONCOLOGICA","ACTA ONCOL","0284-186X","1651-226X","ONCOLOGY - SCIE","9,685","3.1","Q3","0.54","30.31"%,
"Translational Vision Science & Technology","TRANSL VIS SCI TECHN","2164-2591","2164-2591","OPHTHALMOLOGY - SCIE","4,491","3","Q2","1.16","98.78"%,
"Journal of Geriatric Oncology","J GERIATR ONCOL","1879-4068","1879-4076","ONCOLOGY - SCIE","3,069","3","Q3","0.71","15.61"%,
"CANCER CHEMOTHERAPY AND PHARMACOLOGY","CANCER CHEMOTH PHARM","0344-5704","1432-0843","ONCOLOGY - SCIE","10,905","3","Q3","0.7","24.75"%,
"Hormones & Cancer","HORM CANCER-US","1868-8497","1868-8500","ONCOLOGY - SCIE","890","3","Q3","0.68","13.04"%,
"NEOPLASMA","NEOPLASMA","0028-2685","1338-4317","ONCOLOGY - SCIE","3,079","3","Q3","0.62","0.97"%,
"World Journal of Gastrointestinal Oncology","WORLD J GASTRO ONCOL","1948-5204","1948-5204","ONCOLOGY - SCIE","2,515","3","Q3","0.49","94.99"%,
"CURRENT CANCER DRUG TARGETS","CURR CANCER DRUG TAR","1568-0096","1873-5576","ONCOLOGY - SCIE","3,540","3","Q3","0.45","0.95"%,
"Ophthalmology Glaucoma","OPHTHALMOL GLAUCOMA","2589-4234","2589-4196","OPHTHALMOLOGY - ESCI","684","2.9","N/A","1.11","18.03"%,
"OPHTHALMIC AND PHYSIOLOGICAL OPTICS","OPHTHAL PHYSL OPT","0275-5408","1475-1313","OPHTHALMOLOGY - SCIE","4,251","2.9","Q2","1.03","21.43"%,
"Journal of Ophthalmic Inflammation and Infection","J OPHTHALMIC INFLAMM","1869-5760","1869-5760","OPHTHALMOLOGY - ESCI","879","2.9","N/A","0.84","100"%,
"INTEGRATIVE CANCER THERAPIES","INTEGR CANCER THER","1534-7354","1552-695X","ONCOLOGY - SCIE","3,326","2.9","Q3","0.67","92.41"%,
"Thoracic Cancer","THORAC CANCER","1759-7706","1759-7714","ONCOLOGY - SCIE","5,557","2.9","Q3","0.61","69.1"%,
"Oncology Letters","ONCOL LETT","1792-1074","1792-1082","ONCOLOGY - SCIE","28,011","2.9","Q3","0.56","98.18"%,
"NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL","NUTR CANCER","0163-5581","1532-7914","ONCOLOGY - SCIE","8,086","2.9","Q3","0.49","3.51"%,
"Breast Cancer-Basic and Clinical Research","BREAST CANCER-BASIC","1178-2234","1178-2234","ONCOLOGY - ESCI","724","2.9","N/A","0.44","97.5"%,
"Current Hematologic Malignancy Reports","CURR HEMATOL MALIG R","1558-8211","1558-822X","ONCOLOGY - SCIE","1,351","2.9","Q3","0.44","6.15"%,
"JOURNAL OF CATARACT AND REFRACTIVE SURGERY","J CATARACT REFR SURG","0886-3350","1873-4502","OPHTHALMOLOGY - SCIE","14,228","2.8","Q2","1.19","8.48"%,
"CORNEA","CORNEA","0277-3740","1536-4798","OPHTHALMOLOGY - SCIE","13,327","2.8","Q2","1.16","5.86"%,
"European Journal of Oncology Nursing","EUR J ONCOL NURS","1462-3889","1532-2122","ONCOLOGY - SCIE","3,868","2.8","Q3","0.97","17.36"%,
"Quality Technology and Quantitative Management","QUAL TECHNOL QUANT M","1684-3703","1811-4857","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","771","2.8","Q2","0.73","1.4"%,
"PATHOLOGY & ONCOLOGY RESEARCH","PATHOL ONCOL RES","1219-4956","1532-2807","ONCOLOGY - SCIE","3,917","2.8","Q3","0.69","60.5"%,
"JMIR Cancer","JMIR CANCER","2369-1999","2369-1999","ONCOLOGY - ESCI","562","2.8","N/A","0.59","98.62"%,
"Anti-Cancer Agents in Medicinal Chemistry","ANTI-CANCER AGENT ME","1871-5206","1875-5992","ONCOLOGY - SCIE","5,855","2.8","Q3","0.54","1.14"%,
"Recent Patents on Anti-Cancer Drug Discovery","RECENT PAT ANTI-CANC","1574-8928","2212-3970","ONCOLOGY - SCIE","1,066","2.8","Q3","0.49","0"%,
"TECHNOLOGY IN CANCER RESEARCH & TREATMENT","TECHNOL CANCER RES T","1533-0346","1533-0338","ONCOLOGY - SCIE","4,611","2.8","Q3","0.48","94.55"%,
"INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT","INT J TECHNOL MANAGE","0267-5730","1741-5276","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,208","2.8","Q2","0.44","0.81"%,
"Blood and Lymphatic Cancer-Targets and Therapy","BLOOD LYMPHAT CANCER","1179-9889","1179-9889","ONCOLOGY - ESCI","91","2.8","N/A","0.39","100"%,
"World Journal of Clinical Oncology","WORLD J CLIN ONCOL","2218-4333","2218-4333","ONCOLOGY - ESCI","1,782","2.8","N/A","0.37","99.59"%,
"Chinese Clinical Oncology","CHIN CLIN ONCOL","2304-3865","2304-3873","ONCOLOGY - ESCI","1,525","2.8","N/A","0.28","99.3"%,
"GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY","GRAEF ARCH CLIN EXP","0721-832X","1435-702X","OPHTHALMOLOGY - SCIE","11,731","2.7","Q2","1.05","24.3"%,
"MATHEMATICAL PROGRAMMING","MATH PROGRAM","0025-5610","1436-4646","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","14,099","2.7","Q2","1.04","28.52"%,
"UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS","UROL ONCOL-SEMIN ORI","1078-1439","1873-2496","ONCOLOGY - SCIE","7,406","2.7","Q3","0.71","6.69"%,
"ENGINEERING OPTIMIZATION","ENG OPTIMIZ","0305-215X","1029-0273","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","4,257","2.7","Q2","0.68","4.86"%,
"Operational Research","OPER RES-GER","1109-2858","1866-1505","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,494","2.7","Q2","0.65","5.88"%,
"OPERATIONS RESEARCH","OPER RES","0030-364X","N/A","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","17,609","2.7","Q2","0.65","0"%,
"Flexible Services and Manufacturing Journal","FLEX SERV MANUF J","1936-6582","1936-6590","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","956","2.7","Q2","0.49","22.79"%,
"LEUKEMIA RESEARCH","LEUKEMIA RES","0145-2126","1873-5835","ONCOLOGY - SCIE","5,973","2.7","Q3","0.49","11.45"%,
"OR SPECTRUM","OR SPECTRUM","0171-6468","1436-6304","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,040","2.7","Q2","0.47","46.03"%,
"Clinical Lymphoma Myeloma & Leukemia","CL LYMPH MYELOM LEUK","2152-2650","2152-2669","ONCOLOGY - SCIE","4,001","2.7","Q3","0.44","15.97"%,
"Oncology and Therapy","ONCOL THER","2366-1070","2366-1089","ONCOLOGY - ESCI","393","2.7","N/A","0.4","100"%,
"OPHTHALMOLOGICA","OPHTHALMOLOGICA","0030-3755","1423-0267","OPHTHALMOLOGY - SCIE","2,735","2.6","Q2","1.16","15.47"%,
"CANCER NURSING","CANCER NURS","0162-220X","1538-9804","ONCOLOGY - SCIE","4,414","2.6","Q3","0.95","5.07"%,
"Cancer Epidemiology","CANCER EPIDEMIOL","1877-7821","1877-783X","ONCOLOGY - SCIE","4,587","2.6","Q3","0.7","18.78"%,
"Breast Cancer-Targets and Therapy","BREAST CANCER-TARGET","1179-1314","1179-1314","ONCOLOGY - SCIE","1,135","2.6","Q3","0.56","97.52"%,
"SYSTEMS & CONTROL LETTERS","SYST CONTROL LETT","0167-6911","1872-7956","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","9,481","2.6","Q2","0.54","17.06"%,
"IISE Transactions","IISE TRANS","2472-5854","2472-5862","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,549","2.6","Q2","0.53","4"%,
"Current Oncology","CURR ONCOL","1198-0052","1718-7729","ONCOLOGY - SCIE","4,970","2.6","Q3","0.49","99.17"%,
"CURRENT PROBLEMS IN CANCER","CURR PROB CANCER","0147-0272","1535-6345","ONCOLOGY - SCIE","1,449","2.6","Q3","0.48","13.43"%,
"AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS","AM J CLIN ONCOL-CANC","0277-3732","1537-453X","ONCOLOGY - SCIE","5,060","2.6","Q3","0.47","5.52"%,
"Cancer Control","CANCER CONTROL","1073-2748","1526-2359","ONCOLOGY - SCIE","2,540","2.6","Q3","0.44","92.89"%,
"LEUKEMIA & LYMPHOMA","LEUKEMIA LYMPHOMA","1042-8194","1029-2403","ONCOLOGY - SCIE","10,144","2.6","Q3","0.4","13"%,
"JOURNAL OF SURGICAL ONCOLOGY","J SURG ONCOL","0022-4790","1096-9098","ONCOLOGY - SCIE","13,628","2.5","Q4","0.76","5.94"%,
"JOURNAL OF QUALITY TECHNOLOGY","J QUAL TECHNOL","0022-4065","2575-6230","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,951","2.5","Q2","0.65","9.09"%,
"Cancer Genomics & Proteomics","CANCER GENOM PROTEOM","1109-6535","1790-6245","ONCOLOGY - SCIE","1,594","2.5","Q4","0.64","98.96"%,
"JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA","J MAMMARY GLAND BIOL","1083-3021","1573-7039","ONCOLOGY - SCIE","2,049","2.5","Q4","0.58","42.67"%,
"Therapeutic Advances in Ophthalmology","THER ADV OPHTHALMOL","2515-8414","2515-8414","OPHTHALMOLOGY - ESCI","466","2.5","N/A","0.58","95.57"%,
"Journal of Gastric Cancer","J GASTRIC CANCER","2093-582X","2093-5641","ONCOLOGY - SCIE","964","2.5","Q4","0.57","17.92"%,
"Operations Research Perspectives","OPER RES PERSPECT","N/A","2214-7160","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","799","2.5","Q2","0.57","97.62"%,
"Journal of Simulation","J SIMUL","1747-7778","1747-7786","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","886","2.5","Q2","0.48","15.07"%,
"Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis","J ENV SCI HEAL C-TOX","2689-6583","2689-6591","ONCOLOGY - SCIE","94","2.5","Q4","0.46","2"%,
"Journal of Cancer Prevention","J CANCER PREV","2288-3649","2288-3657","ONCOLOGY - ESCI","1,014","2.5","N/A","0.44","98.8"%,
"Eurasian Journal of Medicine and Oncology","EURASIAN J MED ONCOL","N/A","2587-196X","ONCOLOGY - ESCI","286","2.5","N/A","0.35","96.95"%,
"JOURNAL OF REFRACTIVE SURGERY","J REFRACT SURG","1081-597X","1938-2391","OPHTHALMOLOGY - SCIE","4,688","2.4","Q2","1.11","10.61"%,
"JAPANESE JOURNAL OF OPHTHALMOLOGY","JPN J OPHTHALMOL","0021-5155","1613-2246","OPHTHALMOLOGY - SCIE","2,765","2.4","Q2","0.97","0"%,
"BMJ Open Ophthalmology","BMJ OPEN OPHTHALMOL","2397-3269","2397-3269","OPHTHALMOLOGY - ESCI","917","2.4","N/A","0.9","98.52"%,
"Radiology and Oncology","RADIOL ONCOL","1318-2099","1581-3207","ONCOLOGY - SCIE","1,500","2.4","Q4","0.64","96.72"%,
"HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA","HEMATOL ONCOL CLIN N","0889-8588","1558-1977","ONCOLOGY - SCIE","3,303","2.4","Q4","0.54","8.75"%,
"NETWORKS & SPATIAL ECONOMICS","NETW SPAT ECON","1566-113X","1572-9427","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,533","2.4","Q3","0.49","20.34"%,
"Journal of Breast Cancer","J BREAST CANCER","1738-6756","2092-9900","ONCOLOGY - SCIE","1,567","2.4","Q4","0.47","100"%,
"EURO Journal on Transportation and Logistics","EURO J TRANSP LOGIST","2192-4376","2192-4384","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","609","2.4","N/A","0.46","96.88"%,
"JAPANESE JOURNAL OF CLINICAL ONCOLOGY","JPN J CLIN ONCOL","0368-2811","1465-3621","ONCOLOGY - SCIE","6,072","2.4","Q4","0.46","16.13"%,
"EUROPEAN JOURNAL OF CANCER PREVENTION","EUR J CANCER PREV","0959-8278","1473-5709","ONCOLOGY - SCIE","2,951","2.4","Q4","0.44","10.05"%,
"CANCER INVESTIGATION","CANCER INVEST","0735-7907","1532-4192","ONCOLOGY - SCIE","2,910","2.4","Q4","0.41","5.35"%,
"EURO Journal on Computational Optimization","EURO J COMPUT OPTIM","2192-4406","2192-4414","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","309","2.4","N/A","0.4","100"%,
"Oncology Research and Treatment","ONCOL RES TREAT","2296-5270","2296-5262","ONCOLOGY - SCIE","1,501","2.4","Q4","0.39","14.35"%,
"Journal of Optometry","J OPTOM","1888-4296","1989-1342","OPHTHALMOLOGY - ESCI","789","2.3","N/A","0.99","99.12"%,
"Eye & Contact Lens-Science and Clinical Practice","EYE CONTACT LENS","1542-2321","1542-233X","OPHTHALMOLOGY - SCIE","2,792","2.3","Q3","0.93","6.64"%,
"International Journal of Retina and Vitreous","INT J RETINA VITR","N/A","2056-9920","OPHTHALMOLOGY - ESCI","918","2.3","N/A","0.78","100"%,
"JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS","J OCUL PHARMACOL TH","1080-7683","1557-7732","OPHTHALMOLOGY - SCIE","2,904","2.3","Q3","0.75","17.11"%,
"Advances in Radiation Oncology","ADV RADIAT ONCOL","N/A","2452-1094","ONCOLOGY - ESCI","1,870","2.3","N/A","0.67","95.96"%,
"SURGICAL ONCOLOGY-OXFORD","SURG ONCOL","0960-7404","1879-3320","ONCOLOGY - SCIE","3,461","2.3","Q4","0.66","10.08"%,
"QUALITY AND RELIABILITY ENGINEERING INTERNATIONAL","QUAL RELIAB ENG INT","0748-8017","1099-1638","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","4,174","2.3","Q3","0.59","5.3"%,
"ANTI-CANCER DRUGS","ANTI-CANCER DRUG","0959-4973","1473-5741","ONCOLOGY - SCIE","4,578","2.3","Q4","0.58","14.42"%,
"CANCER CAUSES & CONTROL","CANCER CAUSE CONTROL","0957-5243","1573-7225","ONCOLOGY - SCIE","8,013","2.3","Q4","0.55","18.61"%,
"NAVAL RESEARCH LOGISTICS","NAV RES LOG","0894-069X","1520-6750","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","4,011","2.3","Q3","0.38","9.9"%,
"Radiation Oncology Journal","RADIAT ONCOL J","2234-3156","2234-3156","ONCOLOGY - ESCI","729","2.3","N/A","0.35","100"%,
"Tumori Journal","TUMORI J","0300-8916","2038-2529","ONCOLOGY - SCIE","2,313","2.3","Q4","0.34","8"%,
"Clinical Ophthalmology","CLIN OPHTHALMOL","1177-5483","1177-5483","OPHTHALMOLOGY - ESCI","8,352","2.2","N/A","0.79","97.46"%,
"OPTIMIZATION","OPTIMIZATION","0233-1934","1029-4945","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,430","2.2","Q3","0.77","1.69"%,
"COMPUTATIONAL OPTIMIZATION AND APPLICATIONS","COMPUT OPTIM APPL","0926-6003","1573-2894","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,385","2.2","Q3","0.74","23.59"%,
"Seminars in Oncology Nursing","SEMIN ONCOL NURS","0749-2081","1878-3449","ONCOLOGY - SCIE","2,072","2.2","Q4","0.74","6.94"%,
"OPTIMIZATION METHODS & SOFTWARE","OPTIM METHOD SOFTW","1055-6788","1029-4937","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,342","2.2","Q3","0.69","8.88"%,
"MELANOMA RESEARCH","MELANOMA RES","0960-8931","1473-5636","ONCOLOGY - SCIE","2,890","2.2","Q4","0.68","12.83"%,
"MOLECULAR VISION","MOL VIS","1090-0535","N/A","OPHTHALMOLOGY - SCIE","5,955","2.2","Q3","0.66","0"%,
"American Journal of Translational Research","AM J TRANSL RES","1943-8141","1943-8141","ONCOLOGY - SCIE","13,883","2.2","Q4","0.56","0.07"%,
"Familial Cancer","FAM CANCER","1389-9600","1573-7292","ONCOLOGY - SCIE","1,995","2.2","Q4","0.5","32.5"%,
"Discover Oncology","DISCOV ONCOL","N/A","2730-6011","ONCOLOGY - SCIE","197","2.2","Q4","0.44","99.51"%,
"Clinical Medicine Insights-Oncology","CLIN MED INSIGHTS-ON","N/A","1179-5549","ONCOLOGY - SCIE","624","2.2","Q4","0.37","62.16"%,
"CANCER JOURNAL","CANCER J","1528-9117","1540-336X","ONCOLOGY - SCIE","3,293","2.2","Q4","0.27","3.52"%,
"OPHTHALMIC RESEARCH","OPHTHALMIC RES","0030-3747","1423-0259","OPHTHALMOLOGY - SCIE","2,283","2.1","Q3","1.01","53.69"%,
"EUROPEAN JOURNAL OF CANCER CARE","EUR J CANCER CARE","0961-5423","1365-2354","ONCOLOGY - SCIE","5,067","2.1","Q4","0.75","79.02"%,
"OPTIMIZATION AND ENGINEERING","OPTIM ENG","1389-4420","1573-2924","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,591","2.1","Q3","0.67","30.49"%,
"Journal of Eye Movement Research","J EYE MOVEMENT RES","1995-8692","1995-8692","OPHTHALMOLOGY - SCIE","711","2.1","Q3","0.61","97.65"%,
"Breast Care","BREAST CARE","1661-3791","1661-3805","ONCOLOGY - SCIE","1,558","2.1","Q4","0.54","21.93"%,
"INFORMS JOURNAL ON COMPUTING","INFORMS J COMPUT","1091-9856","1526-5528","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,978","2.1","Q3","0.47","0"%,
"Breast Journal","BREAST J","1075-122X","1524-4741","ONCOLOGY - SCIE","3,626","2.1","Q4","0.45","67.22"%,
"Proceedings of the Institution of Mechanical Engineers Part O-Journal of Risk and Reliability","P I MECH ENG O-J RIS","1748-006X","1748-0078","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,340","2.1","Q3","0.44","2.73"%,
"Journal of Gastrointestinal Oncology","J GASTROINTEST ONCOL","2078-6891","2219-679X","ONCOLOGY - SCIE","3,533","2.1","Q4","0.42","96.12"%,
"NETWORKS","NETWORKS","0028-3045","1097-0037","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,596","2.1","Q3","0.4","25.91"%,
"Hematology Transfusion and Cell Therapy","HEMATOL TRANSF CELL","2531-1379","2531-1379","ONCOLOGY - ESCI","567","2.1","N/A","0.35","95.67"%,
"Journal of Systems Engineering and Electronics","J SYST ENG ELECTRON","1004-4132","1004-4132","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,229","2.1","Q3","0.32","94.07"%,
"Molecular & Cellular Oncology","MOL CELL ONCOL","N/A","2372-3556","ONCOLOGY - ESCI","1,294","2.1","N/A","0.25","49.58"%,
"CURRENT EYE RESEARCH","CURR EYE RES","0271-3683","1460-2202","OPHTHALMOLOGY - SCIE","6,730","2","Q3","0.85","8.44"%,
"JOURNAL OF GLAUCOMA","J GLAUCOMA","1057-0829","1536-481X","OPHTHALMOLOGY - SCIE","5,972","2","Q3","0.84","36.33"%,
"BMC Ophthalmology","BMC OPHTHALMOL","N/A","1471-2415","OPHTHALMOLOGY - SCIE","6,070","2","Q3","0.77","99.86"%,
"OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY","OPHTHAL PLAST RECONS","0740-9303","1537-2677","OPHTHALMOLOGY - SCIE","4,109","2","Q3","0.73","1.37"%,
"Journal of Ophthalmic & Vision Research","J OPHTHAL VIS RES","2008-2010","2008-322X","OPHTHALMOLOGY - ESCI","1,442","2","N/A","0.65","100"%,
"Cancer Informatics","CANCER INFORM","N/A","1176-9351","ONCOLOGY - ESCI","876","2","N/A","0.49","73.86"%,
"JOURNAL OF RADIATION RESEARCH","J RADIAT RES","0449-3060","1349-9157","ONCOLOGY - SCIE","3,576","2","Q4","0.49","91.98"%,
"INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS","INT J BIOL MARKER","0393-6155","1724-6008","ONCOLOGY - SCIE","1,331","2","Q4","0.48","94.57"%,
"DISCRETE EVENT DYNAMIC SYSTEMS-THEORY AND APPLICATIONS","DISCRETE EVENT DYN S","0924-6703","1573-7594","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","742","2","Q3","0.44","21.43"%,
"ANTICANCER RESEARCH","ANTICANCER RES","0250-7005","1791-7530","ONCOLOGY - SCIE","24,285","2","Q4","0.42","9.22"%,
"4OR-A Quarterly Journal of Operations Research","4OR-Q J OPER RES","1619-4500","1614-2411","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","761","2","Q3","0.39","19.32"%,
"JOURNAL OF SCHEDULING","J SCHEDULING","1094-6136","1099-1425","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,639","2","Q3","0.37","28.86"%,
"Systems Engineering","SYSTEMS ENG","1098-1241","1520-6858","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","917","2","Q3","0.33","16.26"%,
"Journal of Adolescent and Young Adult Oncology","J ADOLESC YOUNG ADUL","2156-5333","2156-535X","ONCOLOGY - SCIE","1,535","2","Q4","0.32","3.54"%,
"Journal of Pancreatic Cancer","J PANCREATIC CANCER","N/A","2475-3246","ONCOLOGY - ESCI","128","2","N/A","0.31","100"%,
"JOURNAL OF OPTIMIZATION THEORY AND APPLICATIONS","J OPTIMIZ THEORY APP","0022-3239","1573-2878","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","8,177","1.9","Q3","0.72","17.63"%,
"Clinical and Experimental Optometry","CLIN EXP OPTOM","0816-4622","1444-0938","OPHTHALMOLOGY - SCIE","3,092","1.9","Q3","0.7","5.51"%,
"Journal of Ophthalmology","J OPHTHALMOL","2090-004X","2090-0058","OPHTHALMOLOGY - SCIE","5,274","1.9","Q3","0.62","99.51"%,
"Surgical Oncology Clinics of North America","SURG ONCOL CLIN N AM","1055-3207","1558-5042","ONCOLOGY - SCIE","1,979","1.9","Q4","0.62","0"%,
"ONCOLOGY NURSING FORUM","ONCOL NURS FORUM","0190-535X","1538-0688","ONCOLOGY - SCIE","3,897","1.9","Q4","0.61","0"%,
"Brachytherapy","BRACHYTHERAPY","1538-4721","1873-1449","ONCOLOGY - SCIE","2,455","1.9","Q4","0.48","6.93"%,
"VISUAL NEUROSCIENCE","VISUAL NEUROSCI","0952-5238","1469-8714","OPHTHALMOLOGY - SCIE","1,890","1.9","Q3","0.47","19.23"%,
"Cancer Genetics","CANCER GENET-NY","2210-7762","2210-7770","ONCOLOGY - SCIE","1,473","1.9","Q4","0.42","15"%,
"Decision Science Letters","DECISION SCI LETT","1929-5804","1929-5812","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","596","1.9","N/A","0.4","62.6"%,
"International Journal of Breast Cancer","INT J BREAST CANCER","2090-3170","2090-3189","ONCOLOGY - ESCI","549","1.9","N/A","0.34","100"%,
"Asia-Pacific Journal of Clinical Oncology","ASIA-PAC J CLIN ONCO","1743-7555","1743-7563","ONCOLOGY - SCIE","1,989","1.9","Q4","0.32","11.69"%,
"Journal of Cancer Metastasis and Treatment","J CANCER METAS TREAT","2394-4722","2454-2857","ONCOLOGY - ESCI","692","1.9","N/A","0.22","98.74"%,
"JOURNAL OF VISION","J VISION","1534-7362","N/A","OPHTHALMOLOGY - SCIE","8,815","1.8","Q3","0.75","96.87"%,
"VISION RESEARCH","VISION RES","0042-6989","1878-5646","OPHTHALMOLOGY - SCIE","14,405","1.8","Q3","0.67","47.63"%,
"JOURNAL OF GLOBAL OPTIMIZATION","J GLOBAL OPTIM","0925-5001","1573-2916","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","7,518","1.8","Q3","0.66","17.7"%,
"OPHTHALMIC EPIDEMIOLOGY","OPHTHAL EPIDEMIOL","0928-6586","1744-5086","OPHTHALMOLOGY - SCIE","2,464","1.8","Q3","0.64","15.19"%,
"OPTIMAL CONTROL APPLICATIONS & METHODS","OPTIM CONTR APPL MET","0143-2087","1099-1514","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,952","1.8","Q3","0.53","3.88"%,
"Pleura and Peritoneum","PLEURA PERITONEUM","2364-7671","2364-768X","ONCOLOGY - ESCI","340","1.8","N/A","0.52","83.87"%,
"Journal of Cancer Epidemiology","J CANCER EPIDEMIOL","1687-8558","1687-8566","ONCOLOGY - ESCI","512","1.8","N/A","0.51","100"%,
"eCancerMedicalScience","ECANCERMEDICALSCIENC","1754-6605","1754-6605","ONCOLOGY - ESCI","2,190","1.8","N/A","0.46","96.99"%,
"CRIMINAL JUSTICE STUDIES","CRIM JUSTICE STUD","1478-601X","1478-6028","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","511","1.8","N/A","0.45","2.67"%,
"JOURNAL OF CHEMOTHERAPY","J CHEMOTHERAPY","1120-009X","1973-9478","ONCOLOGY - SCIE","1,863","1.8","Q4","0.44","1.64"%,
"RAIRO-OPERATIONS RESEARCH","RAIRO-OPER RES","0399-0559","2804-7303","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,720","1.8","Q3","0.43","50.77"%,
"Journal of the Egyptian National Cancer Institute","J EGYPT NATL CANCER","1110-0362","2589-0409","ONCOLOGY - ESCI","603","1.8","N/A","0.3","99.28"%,
"Wspolczesna Onkologia-Contemporary Oncology","WSPOLCZESNA ONKOL","1428-2526","1897-4309","ONCOLOGY - ESCI","1,371","1.8","N/A","0.25","97.58"%,
"MATHEMATICS OF OPERATIONS RESEARCH","MATH OPER RES","0364-765X","1526-5471","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","5,302","1.7","Q4","0.64","0"%,
"Seminars in Ophthalmology","SEMIN OPHTHALMOL","0882-0538","1744-5205","OPHTHALMOLOGY - SCIE","2,074","1.7","Q4","0.63","4.63"%,
"EUROPEAN JOURNAL OF OPHTHALMOLOGY","EUR J OPHTHALMOL","1120-6721","1724-6016","OPHTHALMOLOGY - SCIE","5,235","1.7","Q4","0.62","3.22"%,
"IMA Journal of Management Mathematics","IMA J MANAG MATH","1471-678X","1471-6798","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","626","1.7","Q4","0.58","7.77"%,
"Journal of Pediatric Oncology Nursing","J PEDIATR ONCOL NURS","1043-4542","1532-8457","ONCOLOGY - SCIE","1,427","1.7","Q4","0.58","2.53"%,
"Clinical Optometry","CLIN OPTOM","1179-2752","1179-2752","OPHTHALMOLOGY - ESCI","346","1.7","N/A","0.56","96.51"%,
"PERCEPTION","PERCEPTION","0301-0066","1468-4233","OPHTHALMOLOGY - SCIE","5,007","1.7","Q4","0.46","23.26"%,
"Central European Journal of Operations Research","CENT EUR J OPER RES","1435-246X","1613-9178","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,131","1.7","Q4","0.45","39.91"%,
"International Journal of Particle Therapy","INT J PART THER","N/A","2331-5180","ONCOLOGY - ESCI","419","1.7","N/A","0.4","97.35"%,
"PEDIATRIC HEMATOLOGY AND ONCOLOGY","PEDIATR HEMAT ONCOL","0888-0018","1521-0669","ONCOLOGY - SCIE","1,791","1.7","Q4","0.39","2.9"%,
"Hereditary Cancer in Clinical Practice","HERED CANCER CLIN PR","1731-2302","1897-4287","ONCOLOGY - SCIE","551","1.7","Q4","0.35","100"%,
"Top","TOP","1134-5764","1863-8279","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","657","1.7","Q4","0.33","16.51"%,
"Cancer Reports","CANCER REP-US","N/A","2573-8348","ONCOLOGY - ESCI","794","1.7","N/A","0.31","59.06"%,
"INTERNATIONAL OPHTHALMOLOGY","INT OPHTHALMOL","0165-5701","1573-2630","OPHTHALMOLOGY - SCIE","4,830","1.6","Q4","0.65","11.56"%,
"JOURNAL OF CANCER EDUCATION","J CANCER EDUC","0885-8195","1543-0154","ONCOLOGY - SCIE","3,420","1.6","Q4","0.59","14.54"%,
"Cutaneous and Ocular Toxicology","CUTAN OCUL TOXICOL","1556-9527","1556-9535","OPHTHALMOLOGY - SCIE","1,095","1.6","Q4","0.55","4.64"%,
"Optimization Letters","OPTIM LETT","1862-4472","1862-4480","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","2,429","1.6","Q4","0.55","12.23"%,
"JOURNAL OF AAPOS","J AAPOS","1091-8531","1528-3933","OPHTHALMOLOGY - SCIE","3,848","1.6","Q4","0.54","3.44"%,
"SORT-Statistics and Operations Research Transactions","SORT-STAT OPER RES T","1696-2281","2013-8830","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","238","1.6","Q4","0.5","2.78"%,
"International Journal of Mathematical Engineering and Management Sciences","INT J MATH ENG MANAG","2455-7749","2455-7749","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","531","1.6","N/A","0.48","100"%,
"Opsearch","OPSEARCH","0030-3887","0975-0320","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","746","1.6","N/A","0.35","1.01"%,
"Studies in Informatics and Control","STUD INFORM CONTROL","1220-1766","N/A","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","593","1.6","Q4","0.34","0"%,
"European Journal of Breast Health","EUR J BREAST HEALTH","N/A","2587-0831","ONCOLOGY - ESCI","422","1.6","N/A","0.32","100"%,
"Journal of Gastrointestinal Cancer","J GASTROINTEST CANC","1941-6628","1941-6636","ONCOLOGY - ESCI","2,015","1.6","N/A","0.3","4.93"%,
"Journal of Kidney Cancer and VHL","J KIDNEY CANCER VHL","2203-5826","2203-5826","ONCOLOGY - ESCI","215","1.6","N/A","0.22","93.62"%,
"Journal of Current Ophthalmology","J CURR OPHTHALMOL","2452-2325","2452-2325","OPHTHALMOLOGY - ESCI","825","1.5","N/A","0.5","91.06"%,
"Journal of Breast Imaging","J BREAST IMAGING","2631-6110","2631-6129","ONCOLOGY - ESCI","443","1.5","N/A","0.37","4.98"%,
"International Journal of Surgical Oncology","INT J SURG ONCOL","2090-1402","2090-1410","ONCOLOGY - ESCI","410","1.5","N/A","0.29","100"%,
"DOCUMENTA OPHTHALMOLOGICA","DOC OPHTHALMOL","0012-4486","1573-2622","OPHTHALMOLOGY - SCIE","2,067","1.4","Q4","0.68","25"%,
"OPTOMETRY AND VISION SCIENCE","OPTOMETRY VISION SCI","1040-5488","1538-9235","OPHTHALMOLOGY - SCIE","7,028","1.4","Q4","0.63","10.53"%,
"International Journal of Ophthalmology","INT J OPHTHALMOL-CHI","2222-3959","2227-4898","OPHTHALMOLOGY - SCIE","4,057","1.4","Q4","0.54","100"%,
"APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY","APPL STOCH MODEL BUS","1524-1904","1526-4025","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,298","1.4","Q4","0.45","10.78"%,
"International Journal of Clinical and Experimental Pathology","INT J CLIN EXP PATHO","1936-2625","1936-2625","ONCOLOGY - ESCI","10,150","1.4","N/A","0.39","0"%,
"Journal of Contemporary Brachytherapy","J CONTEMP BRACHYTHER","1689-832X","2081-2841","ONCOLOGY - SCIE","881","1.4","Q4","0.32","99.57"%,
"ASIA-PACIFIC JOURNAL OF OPERATIONAL RESEARCH","ASIA PAC J OPER RES","0217-5959","1793-7019","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","866","1.4","Q4","0.24","0.45"%,
"INFORMS Journal on Applied Analytics","INFORMS J APPL ANAL","2644-0865","2644-0873","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","157","1.4","Q4","0.24","1.02"%,
"Journal of the Operations Research Society of China","J OPER RES SOC CHINA","2194-668X","2194-6698","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","363","1.4","N/A","0.24","4.66"%,
"Journal of Industrial and Management Optimization","J IND MANAG OPTIM","1547-5816","1553-166X","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,776","1.3","Q4","0.43","99.19"%,
"JOURNAL OF ONCOLOGY PHARMACY PRACTICE","J ONCOL PHARM PRACT","1078-1552","1477-092X","ONCOLOGY - SCIE","2,445","1.3","Q4","0.29","3.97"%,
"Cancer Radiotherapie","CANCER RADIOTHER","1278-3218","1769-6658","ONCOLOGY - SCIE","1,316","1.3","Q4","0.26","25.07"%,
"INFOR","INFOR","0315-5986","1916-0615","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","621","1.3","Q4","0.24","5.26"%,
"Journal of Cancer Research and Therapeutics","J CANCER RES THER","0973-1482","1998-4138","ONCOLOGY - SCIE","4,376","1.3","Q4","0.23","93.26"%,
"MATHEMATICAL METHODS OF OPERATIONS RESEARCH","MATH METHOD OPER RES","1432-2994","1432-5217","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,125","1.2","Q4","0.4","38.84"%,
"JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS","J PEDIAT OPHTH STRAB","0191-3913","1938-2405","OPHTHALMOLOGY - SCIE","1,683","1.2","Q4","0.39","5.17"%,
"OPHTHALMIC GENETICS","OPHTHALMIC GENET","1381-6810","1744-5094","OPHTHALMOLOGY - SCIE","1,525","1.2","Q4","0.37","10.05"%,
"JOURNAL FRANCAIS D OPHTALMOLOGIE","J FR OPHTALMOL","0181-5512","1773-0597","OPHTHALMOLOGY - SCIE","1,553","1.2","Q4","0.33","22.22"%,
"JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY","J PEDIAT HEMATOL ONC","1077-4114","1536-3678","ONCOLOGY - SCIE","4,780","1.2","Q4","0.32","2.02"%,
"Medical Dosimetry","MED DOSIM","0958-3947","1873-4022","ONCOLOGY - SCIE","999","1.2","Q4","0.31","4.74"%,
"Journal of Systems Science and Systems Engineering","J SYST SCI SYST ENG","1004-3756","1861-9576","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","833","1.2","Q4","0.28","0"%,
"Molecular and Clinical Oncology","MOL CLIN ONCOL","2049-9450","2049-9469","ONCOLOGY - ESCI","3,163","1.2","N/A","0.28","98.41"%,
"Reports of Practical Oncology and Radiotherapy","REP PRACT ONCOL RADI","1507-1367","2083-4640","ONCOLOGY - ESCI","1,325","1.2","N/A","0.26","0"%,
"QUEUEING SYSTEMS","QUEUEING SYST","0257-0130","1572-9443","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","1,413","1.2","Q4","0.25","14.14"%,
"World Cancer Research Journal","WORLD CANCER RES J","2372-3416","2372-3416","ONCOLOGY - ESCI","352","1.2","N/A","0.21","0"%,
"Kidney Cancer","KIDNEY CANCER","2468-4562","2468-4570","ONCOLOGY - ESCI","160","1.2","N/A","0.19","77.19"%,
"Advances in Operations Research","ADV OPER RES","1687-9147","1687-9155","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","195","1.2","N/A","0.18","100"%,
"BULLETIN DU CANCER","B CANCER","0007-4551","1769-6917","ONCOLOGY - SCIE","1,499","1.2","Q4","0.18","33.26"%,
"ENGINEERING ECONOMIST","ENG ECON","0013-791X","1547-2701","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","481","1.2","Q4","0.15","4.17"%,
"International Journal of Endocrine Oncology","INT J ENDOCR ONCOL","2045-0869","2045-0877","ONCOLOGY - ESCI","76","1.2","N/A","0.09","100"%,
"Orbit-The International Journal on Orbital Disorders-Oculoplastic and Lacrimal Surgery","ORBIT-ABINGDON","0167-6830","1744-5108","OPHTHALMOLOGY - ESCI","1,572","1.1","N/A","0.43","0.68"%,
"Clinical Journal of Oncology Nursing","CLIN J ONCOL NURS","1092-1095","1538-067X","ONCOLOGY - SCIE","1,938","1.1","Q4","0.41","0.42"%,
"Discrete Optimization","DISCRETE OPTIM","1572-5286","1873-636X","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","825","1.1","Q4","0.39","21.33"%,
"PROBABILITY IN THE ENGINEERING AND INFORMATIONAL SCIENCES","PROBAB ENG INFORM SC","0269-9648","1469-8951","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","769","1.1","Q4","0.38","4.57"%,
"Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology","TURK OFTAMOL DERGISI","1300-0659","2147-2661","OPHTHALMOLOGY - ESCI","621","1.1","N/A","0.38","93.94"%,
"Bladder Cancer","BLADDER CANCER","2352-3727","2352-3735","ONCOLOGY - SCIE","549","1.1","Q4","0.26","49.56"%,
"OPERATIONS RESEARCH LETTERS","OPER RES LETT","0167-6377","1872-7468","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","3,811","1.1","Q4","0.24","20.66"%,
"Brazilian Journal of Operations & Production Management","BRAZ J OPER PROD MAN","2237-8960","2237-8960","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","282","1.1","N/A","0.21","96.26"%,
"Ocular Oncology and Pathology","OCUL ONCOL PATHOL","2296-4681","2296-4657","OPHTHALMOLOGY - ESCI","472","1","N/A","0.41","7.45"%,
"Ophthalmic Surgery Lasers & Imaging Retina","OSLI RETINA","2325-8160","2325-8179","OPHTHALMOLOGY - SCIE","2,822","1","Q4","0.41","5.32"%,
"ARQUIVOS BRASILEIROS DE OFTALMOLOGIA","ARQ BRAS OFTALMOL","0004-2749","1678-2925","OPHTHALMOLOGY - SCIE","1,349","1","Q4","0.34","80.08"%,
"Taiwan Journal of Ophthalmology","TAIWAN J OPHTHALMOL","2211-5056","2211-5072","OPHTHALMOLOGY - ESCI","499","1","N/A","0.33","90.4"%,
"International Journal of Knowledge and Systems Science","INT J KNOWL SYST SCI","1947-8208","1947-8216","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","103","1","N/A","0.22","18.18"%,
"European Journal of Industrial Engineering","EUR J IND ENG","1751-5254","1751-5262","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","560","1","Q4","0.21","0"%,
"INDIAN JOURNAL OF CANCER","INDIAN J CANCER","0019-509X","1998-4774","ONCOLOGY - SCIE","1,661","1","Q4","0.19","0"%,
"Journal of Business Analytics","J BUS ANAL","2573-234X","2573-2358","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","99","1","N/A","0.17","12.2"%,
"Clinical Advances in Hematology & Oncology","CLIN ADV HEMATOL ONC","1543-0790","1543-0790","ONCOLOGY - ESCI","883","1","N/A","0.14","0"%,
"Current Ophthalmology Reports","CURR OPHTHALMOL REP","N/A","2167-4868","OPHTHALMOLOGY - ESCI","296","0.9","N/A","0.42","3.66"%,
"Strabismus","STRABISMUS","0927-3972","1744-5132","OPHTHALMOLOGY - ESCI","664","0.9","N/A","0.35","5.71"%,
"Case Reports in Ophthalmological Medicine","CASE REP OPHTHAL MED","2090-6722","2090-6730","OPHTHALMOLOGY - ESCI","377","0.9","N/A","0.31","99.39"%,
"Rehabilitation Oncology","REHABIL ONCOL","2168-3808","2381-2427","ONCOLOGY - ESCI","216","0.9","N/A","0.17","92.11"%,
"Case Reports in Oncological Medicine","CASE REP ONCOL MED","2090-6706","2090-6714","ONCOLOGY - ESCI","564","0.9","N/A","0.16","98.2"%,
"Oncologie","ONCOLOGIE","1292-3818","1765-2839","ONCOLOGY - SCIE","111","0.9","Q4","0.16","70.31"%,
"Current Breast Cancer Reports","CURR BREAST CANCER R","1943-4588","1943-4596","ONCOLOGY - ESCI","370","0.9","N/A","0.15","9.32"%,
"Rare Tumors","RARE TUMORS","2036-3605","2036-3613","ONCOLOGY - ESCI","437","0.9","N/A","0.14","97.3"%,
"Translational Cancer Research","TRANSL CANCER RES","2218-676X","2219-6803","ONCOLOGY - SCIE","2,683","0.9","Q4","0.13","99.76"%,
"Ophthalmologie","OPHTHALMOLOGIE","2731-720X","2731-7218","OPHTHALMOLOGY - SCIE","1,562","0.9","Q4","0.02","37.04"%,
"British Journal of Visual Impairment","BRIT J VISUAL IMPA","0264-6196","1744-5809","OPHTHALMOLOGY - ESCI","450","0.8","N/A","0.35","18.89"%,
"KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE","KLIN MONATSBL AUGENH","0023-2165","1439-3999","OPHTHALMOLOGY - SCIE","1,551","0.8","Q4","0.34","0.87"%,
"Case Reports in Oncology","CASE REP ONCOL","1662-6575","1662-6575","ONCOLOGY - ESCI","1,320","0.8","N/A","0.16","99.43"%,
"Expert Review of Ophthalmology","EXPERT REV OPHTHALMO","1746-9899","1746-9902","OPHTHALMOLOGY - ESCI","516","0.7","N/A","0.2","8.4"%,
"International Cancer Conference Journal","INT CANCER CONF J","2192-3183","2192-3183","ONCOLOGY - ESCI","209","0.7","N/A","0.14","10.31"%,
"International Journal of Applied Management Science","INT J APPL MANAG SCI","1755-8913","1755-8921","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","122","0.7","N/A","0.13","0"%,
"International Journal of Cancer Management","INT J CANCER MANAG","2538-4422","2538-497X","ONCOLOGY - ESCI","344","0.7","N/A","0.12","99.17"%,
"Breast Cancer Management","BREAST CANCER MANAG","1758-1923","1758-1931","ONCOLOGY - ESCI","63","0.7","N/A","0.09","100"%,
"MILITARY OPERATIONS RESEARCH","MIL OPER RES","1082-5983","2163-2758","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","148","0.7","Q4","0.08","0"%,
"Middle East African Journal of Ophthalmology","MIDDLE EAST AFR J OP","0974-9233","0975-1599","OPHTHALMOLOGY - ESCI","1,036","0.6","N/A","0.26","0"%,
"Journal of VitreoRetinal Diseases","J VITREORETINAL DIS","2474-1264","2474-1272","OPHTHALMOLOGY - ESCI","188","0.6","N/A","0.25","2.99"%,
"African Vision and Eye Health Journal","AFR VIS EYE HEALTH J","0378-9411","2410-3039","OPHTHALMOLOGY - ESCI","267","0.6","N/A","0.21","94.34"%,
"FOLIA BIOLOGICA","FOLIA BIOL-PRAGUE","0015-5500","0015-5500","ONCOLOGY - SCIE","475","0.6","Q4","0.16","0"%,
"Memo-Magazine of European Medical Oncology","MEMO-MAG EUR MED ONC","1865-5041","1865-5076","ONCOLOGY - ESCI","287","0.6","N/A","0.11","46.72"%,
"UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi","UHOD-ULUSLAR HEMATOL","1306-133X","1306-133X","ONCOLOGY - SCIE","123","0.6","Q4","0.08","63.04"%,
"Current Cancer Therapy Reviews","CURR CANCER THER REV","1573-3947","1875-6301","ONCOLOGY - ESCI","125","0.6","N/A","0.06","0"%,
"South Asian Journal of Cancer","SOUTH ASIAN J CANCER","2278-330X","2278-4306","ONCOLOGY - ESCI","648","0.5","N/A","0.13","98.48"%,
"Indian Journal of Surgical Oncology","INDIA J SURG ONCOL","0975-7651","0976-6952","ONCOLOGY - ESCI","899","0.5","N/A","0.11","2.79"%,
"Oncology in Clinical Practice","ONCOL CLIN PRACT","2450-1654","2450-6478","ONCOLOGY - ESCI","137","0.5","N/A","0.06","98.23"%,
"Case Reports in Ophthalmology","CASE REP OPHTHALMOL","1663-2699","N/A","OPHTHALMOLOGY - ESCI","602","0.4","N/A","0.22","100"%,
"Saudi Journal of Ophthalmology","SAUDI J OPHTHALMOL","1319-4534","2542-6680","OPHTHALMOLOGY - ESCI","870","0.4","N/A","0.2","0"%,
"EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY","EUR J GYNAECOL ONCOL","0392-2936","2709-0086","ONCOLOGY - SCIE","1,244","0.4","Q4","0.08","98.76"%,
"Operations Research and Decisions","OPER RES DECIS","2081-8858","2081-8858","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - ESCI","107","0.4","N/A","0.08","89.53"%,
"Middle East Journal of Cancer","MIDDLE EAST J CANCER","2008-6709","2008-6687","ONCOLOGY - ESCI","200","0.4","N/A","0.06","0"%,
"Open Ophthalmology Journal","OPEN OPHTHALMOL J","1874-3641","1874-3641","OPHTHALMOLOGY - ESCI","497","0.3","N/A","0.14","95.65"%,
"Nepalese Journal of Ophthalmology","NEPAL J OPHTHALMOL","2072-6805","2091-0320","OPHTHALMOLOGY - ESCI","326","0.3","N/A","0.1","73.57"%,
"Eye Reports","EYE REP","2039-4748","2039-4756","OPHTHALMOLOGY - ESCI","13","0.3","N/A","0.06","0"%,
"Onkologie","ONKOLOGIE-GER","2731-7226","2731-7234","ONCOLOGY - SCIE","201","0.3","Q4","0.05","6.86"%,
"Turk Onkoloji Dergisi-Turkish Journal of Oncology","TURK ONCOL DERG","1300-7467","1300-7467","ONCOLOGY - ESCI","114","0.3","N/A","0.04","99.51"%,
"International Journal of Surgery-Oncology","INT J SURG-ONCOL","2471-3864","2471-3864","ONCOLOGY - ESCI","103","0.3","N/A","0.03","97.62"%,
"Pacific Journal of Optimization","PAC J OPTIM","1348-9151","1348-9151","OPERATIONS RESEARCH & MANAGEMENT SCIENCE - SCIE","457","0.2","Q4","0.11","0"%,
"Journal of the Egyptian Ophthalmological Society","J EGYPT OPHTHALMOL","2090-0686","2314-6648","OPHTHALMOLOGY - ESCI","33","0.2","N/A","0.06","90"%,
"Indian Journal of Medical and Paediatric Oncology","INDIAN J MED PAEDIAT","0971-5851","0975-2129","ONCOLOGY - ESCI","775","0.2","N/A","0.04","99.35"%,
"Revista Colombiana de Cancerologia","REV COLOMB CANCEROL","0123-9015","2346-0199","ONCOLOGY - ESCI","73","0.2","N/A","0.03","73.26"%,
"Uroonkoloji Bulteni-Bulletin of Urooncology","UROONKOLOJI BUL","2147-2270","2147-2270","ONCOLOGY - ESCI","33","0.2","N/A","0.03","100"%,
"Psycho-Oncologie","PSYCHO-ONCOLOGIE","1778-3798","1778-381X","ONCOLOGY - SCIE","71","0.2","Q4","0.02","5.33"%,
"Spektrum der Augenheilkunde","SPEKTRUM AUGENHEILKD","0930-4282","1613-7523","OPHTHALMOLOGY - ESCI","44","0.1","N/A","0.05","34.29"%,
"Journal of the Korean Ophthalmological Society","J KOR OPHTHALMOL SOC","0378-6471","2092-9374","OPHTHALMOLOGY - ESCI","461","0.1","N/A","0.04","99.67"%,
"Clinical Cancer Investigation Journal","CLIN CANCER INVESTIG","2278-0513","2278-0513","ONCOLOGY - ESCI","154","0.1","N/A","0.03","25.18"%,
"Onkourologiya","ONKOUROLOGIYA","1726-9776","1996-1812","ONCOLOGY - ESCI","63","0.1","N/A","0.03","94.81"%,
"Onkologija","ONKOLOGIJA","1408-1741","1581-3215","ONCOLOGY - ESCI","14","0.1","N/A","0.02","0"%,
"Gaceta Mexicana de Oncologia","GAC MEX ONCOL","1665-9201","1665-9201","ONCOLOGY - ESCI","58","0.1","N/A","0.01","97.67"%,
"Augenheilkunde Up2date","AUGENHEILKUND UP2DAT","1616-9719","1616-9735","OPHTHALMOLOGY - ESCI","5","<0.1","N/A","0.05","0"%,
"Journal of Pediatric Hematology-Oncology Nursing","J PEDIAT HEMAT ONC N","2752-7530","2752-7549","ONCOLOGY - SCIE","12","N/A","N/A","0.29","2.56"%,

Copyright (c) 2024 Clarivate 
By exporting the selected data; you agree to the data usage policy set forth in the Terms of Use 
